Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-576-6 | CAS number: 122-80-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- documentation insufficient for assessment
Data source
Reference
- Reference Type:
- publication
- Title:
- Acid violet 7 and its biodegradation products induce chromosome aberrations, lipid peroxidation, and cholinesterase inhibition in mouse bone marrow
- Author:
- H. B. Mansour, Y. Ayed-Ajmi, R. Mosrati, D. Corroler, K. Ghedira, D. Barillier, L. Chekir-Ghedira
- Year:
- 2 010
- Bibliographic source:
- Environ Sci Pollut Res (2010) 17:1371–1378
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Bone marrow cells were obtained according to the technique of Yosida and Amano 1965 (Autosomal polymorphism in laboratory bred and wild Norway rats, Rattus norvegicus. Chromosoma 16:658–667). Chromosomes were prepared as reported by Evans et al. 1960 (An air drying method for meiotic preparation from mammalian tests. Cytogenetics 3:613–616). See: details of tissue and slide preparation.
- GLP compliance:
- no
- Type of assay:
- mammalian bone marrow chromosome aberration test
Test material
- Reference substance name:
- 4'-aminoacetanilide
- EC Number:
- 204-576-6
- EC Name:
- 4'-aminoacetanilide
- Cas Number:
- 122-80-5
- Molecular formula:
- C8H10N2O
- IUPAC Name:
- 4'-aminoacetanilide
- Test material form:
- solid
- Details on test material:
- Name: 4'-aminoacetanilide
Constituent 1
- Specific details on test material used for the study:
- 4’-aminoacetanilide (4’-AA) was obtained from Aldrich (St Louis, MO, USA) and zearalenone were purchased from Sigma–Aldrich (Steinheim, Germany).
Methanol and acetic acid were obtained from Prolabo (Paris, France).
Test animals
- Species:
- mouse
- Strain:
- Balb/c
- Details on species / strain selection:
- Mice of similar age and weight (20–25 g) were selected.
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- Animals were kept for 1 week before the experiments for acclimatization and were maintained on food (conventional chow) and water ad libitum.
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- not specified
- Details on exposure:
- Administration of the tested substance was by intraperitoneal (IP) injection of 200 μl of the solution. Twenty-four hours before sacrifice, animals were given 500 μl of the mixture yeast extract/glucose (at final concentrations 100 and 200 mg/ml, respectively) to accelerate mitosis of bone marrow cells. Vinblastin (200 μl; at final concentration 250 μg/ml) was injected into the animals 45 min before sacrifice, in order to block dividing cells in metaphase. Finally, animals were sacrificed by cervical dislocation.
- Duration of treatment / exposure:
- not specified
- Frequency of treatment:
- A single dose for the groups of negative and positive control. Increasing doses for the group 4'-AA.
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0.5 mg/kg bw (total dose)
- Dose / conc.:
- 1 mg/kg bw (total dose)
- Dose / conc.:
- 2.5 mg/kg bw (total dose)
- No. of animals per sex per dose:
- 3
- Control animals:
- yes
- Positive control(s):
- A single dose of zearalenone (4 mg/kg)
Examinations
- Tissues and cell types examined:
- Bone marrow
- Details of tissue and slide preparation:
- BONE MARROW PREPARATION
Bone marrow cells were obtained according to the technique of Yosida and Amano (1965). Briefly, femur and tibia were removed immediately after animal sacrifice and bone marrow was flushed out with KCl solution (0.075 M, 37 C) using a syringe. The bone marrow cell suspension was incubated for 20 min at 37°C and centrifuged at 3,500 rpm for 10 min. The supernatant was discarded, the pellet was resuspended in 5 ml of a fixative solution (acetic acid/methanol, 1:3, v/v), centrifuged (3,500 rpm for 10 min), and the supernatant was discarded again. This step was repeated three times in order to clean the pellet. Finally, the pellet was resuspended in 1 ml of the above fixative solution and used for chromosome preparation.
CHROMOSOME PREPARATION
Chromosomes were prepared as reported by Evans et al. (1960). Cell suspensions were dropped on glass slides giving smears that were blazed on a flame for 5 s, then air-dried for conservation at room temperature and/or directly stained with Giemsa. Giemsa working solution was freshly prepared (4 ml in 100 ml) in phosphate buffer (0.15 M, pH7.2). Slides were left for 15 min in this staining solution, then rinsed with water and allowed to dry at room temperature.
SLIDE ANALYSIS
The slides were examined under 100× magnifications using an optical microscope (Carl Zeiss, Oberkochen, Germany). Three hundred well-spread metaphases were analyzed per group for abnormalities. Metaphases with chromosome breaks, gaps, ring, and centric fusion (Robertsonian translocation) were recorded and expressed as percentage of total metaphases per group. - Statistics:
- Data are expressed as mean±standard deviation from three replicates. The statistical analysis was performed with STATISTICA edition 99 France. Duncan test was used to compare tested compounds vs. control. Difference was considered significant when P<0.05.
Results and discussion
Test results
- Sex:
- female
- Genotoxicity:
- positive
- Toxicity:
- yes
- Vehicle controls validity:
- not specified
- Negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Remarks on result:
- other: Important genotoxic potential according to the authors
- Additional information on results:
- 4’-aminoacetanilide showed an important genotoxic potential and the percentage of chromosome aberrations increased significantly (33% at the highest tested dose) which was comparable to the positive control (zearalenone at 20 mg/kg bw).
Any other information on results incl. tables
Tested compound | Dose (mg/kgbw) |
Structural aberration (%) | Total aberration (%) |
|||
Rings | Centric fusion |
Chromosomal breaks |
Gaps | |||
Negative control | 2.5 | 00±0 | 2.5±0.5 | 02.2±0.1 | 02.1±0.5 | 6±1.0 |
Positive control (zearalenone) | 20 | 2.3±1.5 | 21.3±2.5 | 8.3±3.5 | 0.6±0.5 | 33.0±1.0** |
4'-AA | 2.5 | 6.5±0.5 | 15.3±0.6 | 10.5±1.2 | 01.50±0.5 | 34±2** |
1 | 04.2±1.4 | 9.5±0.5 | 6.3±1.1 | 00±00 | 19±1.5* | |
0.5 | 2.5±1.3 | 5.5±0.5 | 3.5±0.5 | 1.5±0.5 | 13±2.5 | |
*P<0.05 **P<0.01 |
Applicant's summary and conclusion
- Conclusions:
- 4’-aminoacetanilide showed an important genotoxic potential in the in vivo mouse bone marrow test.
- Executive summary:
Toxicity of standard 4’-aminoacetanilide (4’-AA) was evaluated in vivo, in mouse bone marrow, by assessing the percentage of cells bearing different chromosome aberrations.
4’-AA showed an important genotoxic potential, the percentage of chromosome aberrations increased significantly (33% at the highest tested dose) which was comparable to the positive control (zearalenone at 20 mg/kg bw).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.